159 related articles for article (PubMed ID: 15072840)
21. A61603-induced contractions of the porcine meningeal artery are mediated by alpha1- and alpha2-adrenoceptors.
Mehrotra S; Gupta S; Centurión D; Villalón CM; Saxena PR; VandenBrink AM
Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):279-85. PubMed ID: 17371533
[TBL] [Abstract][Full Text] [Related]
22. A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists.
Moloney GP; Robertson AD; Martin GR; MacLennan S; Mathews N; Dodsworth S; Sang PY; Knight C; Glen R
J Med Chem; 1997 Jul; 40(15):2347-62. PubMed ID: 9240350
[TBL] [Abstract][Full Text] [Related]
23. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.
Mallams AK; Rossman RR; Doll RJ; Girijavallabhan VM; Ganguly AK; Petrin J; Wang L; Patton R; Bishop WR; Carr DM; Kirschmeier P; Catino JJ; Bryant MS; Chen KJ; Korfmacher WA; Nardo C; Wang S; Nomeir AA; Lin CC; Li Z; Chen J; Lee S; Dell J; Lipari P; Liu M
J Med Chem; 1998 Mar; 41(6):877-93. PubMed ID: 9526562
[TBL] [Abstract][Full Text] [Related]
25. [Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives].
Fu XZ; Tang L; Yuan M; Shi JS
Yao Xue Xue Bao; 2007 Jul; 42(7):735-40. PubMed ID: 17882957
[TBL] [Abstract][Full Text] [Related]
26. Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives.
Takahashi T; Sakuraba A; Hirohashi T; Shibata T; Hirose M; Haga Y; Nonoshita K; Kanno T; Ito J; Iwaasa H; Kanatani A; Fukami T; Sato N
Bioorg Med Chem; 2006 Nov; 14(22):7501-11. PubMed ID: 16919461
[TBL] [Abstract][Full Text] [Related]
27. Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation.
de la Fuente T; Martín-Fontecha M; Sallander J; Benhamú B; Campillo M; Medina RA; Pellissier LP; Claeysen S; Dumuis A; Pardo L; López-Rodríguez ML
J Med Chem; 2010 Feb; 53(3):1357-69. PubMed ID: 20078106
[TBL] [Abstract][Full Text] [Related]
28. Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol.
Rojas-Corrales MO; Berrocoso E; Micó JA
Eur J Pharmacol; 2005 Mar; 511(1):21-6. PubMed ID: 15777775
[TBL] [Abstract][Full Text] [Related]
29. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
[TBL] [Abstract][Full Text] [Related]
30. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD
J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369
[TBL] [Abstract][Full Text] [Related]
31. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor.
Fattori D; Porcelloni M; D'Andrea P; Catalioto RM; Ettorre A; Giuliani S; Marastoni E; Mauro S; Meini S; Rossi C; Altamura M; Maggi CA
J Med Chem; 2010 May; 53(10):4148-65. PubMed ID: 20408549
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of novel quinolone and quinoline-2-carboxylic acid (4-morpholin-4-yl-phenyl)amides: a late-stage diversification approach to potent 5HT1B antagonists.
Horchler CL; McCauley JP; Hall JE; Snyder DH; Craig Moore W; Hudzik TJ; Chapdelaine MJ
Bioorg Med Chem; 2007 Jan; 15(2):939-50. PubMed ID: 17126021
[TBL] [Abstract][Full Text] [Related]
34. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and 5-HT receptors binding studies of some 3-substituted-2-(4-methyl-1-piperazinyl)-4-phenylquinolines.
Anzini M; Cappelli A; Vomero S; Campiani G; Cagnotto A; Skorupska M
Farmaco; 1991 Dec; 46(12):1435-47. PubMed ID: 1668253
[TBL] [Abstract][Full Text] [Related]
36. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
37. Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets.
Jackson MJ; Al-Barghouthy G; Pearce RK; Smith L; Hagan JJ; Jenner P
Pharmacol Biochem Behav; 2004 Nov; 79(3):391-400. PubMed ID: 15582011
[TBL] [Abstract][Full Text] [Related]
38. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada I; Avila D; Marco I; Schiapparelli L; Frechilla D; Del Río J
Bioorg Med Chem; 2004 Oct; 12(19):5181-91. PubMed ID: 15351401
[TBL] [Abstract][Full Text] [Related]
39. Identification of a potent and selective 5-HT1B receptor antagonist.
Wyman PA; Marshall HR; Flynn ST; King RJ; Thompson M; Smith PW; Hadley MS; Price GW; Scott CM; Dawson LA
Bioorg Med Chem Lett; 2005 Nov; 15(21):4708-12. PubMed ID: 16153839
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action.
Tatarczyńska E; Antkiewicz-Michaluk L; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Eur J Pharmacol; 2005 May; 516(1):46-50. PubMed ID: 15913599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
